title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Annexon  ( ANNX )  to Report Q1 Earnings: What's in the Cards?,20240501T141500,https://www.zacks.com/stock/news/2266131/annexon-annx-to-report-q1-earnings-whats-in-the-cards,ALNY,0.137671,Neutral,-0.023677
"Earnings Scheduled For April 28, 2022",20220428T085040,https://www.benzinga.com/news/earnings/22/04/26860440/earnings-scheduled-for-april-28-2022,ALNY,0.014477,Neutral,-0.137174
QURE Soars on FDA Alignment for Speedy Approval of Huntington's Drug,20241211T150200,https://www.zacks.com/stock/news/2382224/qure-soars-on-fda-alignment-for-speedy-approval-of-huntingtons-drug,ALNY,0.211191,Neutral,0.066085
"Biotech Stock Roundup: BMY Grabs MRTX, AKRO Down on Study Data, ALNY Faces Setback",20231012T122400,https://www.zacks.com/stock/news/2164807/biotech-stock-roundup-bmy-grabs-mrtx-akro-down-on-study-data-alny-faces-setback,ALNY,0.134402,Neutral,0.063039
uniQure Announces First Quarter 2022 Financial Results and Highlights Recent Company Progress,20220502T110500,https://www.globenewswire.com/news-release/2022/05/02/2433340/0/en/uniQure-Announces-First-Quarter-2022-Financial-Results-and-Highlights-Recent-Company-Progress.html,ALNY,0.016796,Somewhat-Bullish,0.210379
"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer Bio",20230719T210100,https://www.prnewswire.com/news-releases/hypertension-market-to-accelerate-positively-estimates-delveinsight--key-companies-active-in-the-market---novartis-bayer-merck-insmed-acceleron-abbvie-alnylam--apnimed-astrazeneca-gossamer-bio-301880558.html,ALNY,0.024801,Neutral,0.102776
"Aadi Bioscience, Inc.  ( AADI )  Reports Q4 Loss, Tops Revenue Estimates",20230328T131503,https://www.zacks.com/stock/news/2071261/aadi-bioscience-inc-aadi-reports-q4-loss-tops-revenue-estimates,ALNY,0.2035,Neutral,0.0
Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors - Alkermes  ( NASDAQ:ALKS ) ,20230613T110000,https://www.benzinga.com/pressreleases/23/06/n32831446/alkermes-issues-letter-to-shareholders-highlighting-skills-and-experience-of-refreshed-board-of-di,ALNY,0.019102,Neutral,0.0
"CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio",20230925T210100,https://www.prnewswire.com/news-releases/car-t-cell-therapy-for-multiple-myeloma-market-to-observe-stunning-growth-by-2032-evaluates-delveinsight--key-companies---cartesian-arcellx-novartis-bristol-myers-squibb-carsgen-poseida-juno-crispr-bluebird-bio-301937157.html,ALNY,0.018757,Neutral,0.012868
"Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial",20220803T141314,https://www.benzinga.com/general/biotech/22/08/28331170/biotech-daily-mercks-two-combo-cancer-trials-miss-main-goal-approval-for-sinovacs-covid-19-shot-f,ALNY,0.098659,Neutral,0.0
RNAi Therapeutics Global Market to 2027: Rising Utilization in Oncology Pharmaceuticals and Accelerating Growth Rates of Infectious Diseases Drives Growth,20230316T184500,https://www.prnewswire.com/news-releases/rnai-therapeutics-global-market-to-2027-rising-utilization-in-oncology-pharmaceuticals-and-accelerating-growth-rates-of-infectious-diseases-drives-growth-301774181.html,ALNY,0.044801,Neutral,0.145391
"Dementia Market to Grow Rapidly, Estimates DelveInsight | Key Companies Active in the Market - Pfizer, Eli Lilly and Company, Janssen, Merck, BioVie, Biogen, Vivoryon, Sage, Alnylam, BioXcel, EIP, Otsuka, Alector, Transposon",20230726T210100,https://www.prnewswire.com/news-releases/dementia-market-to-grow-rapidly-estimates-delveinsight--key-companies-active-in-the-market---pfizer-eli-lilly-and-company-janssen-merck-biovie-biogen-vivoryon-sage-alnylam-bioxcel-eip-otsuka-alector-transposon-301885979.html,ALNY,0.023814,Neutral,0.086416
"Cramer Says 'Please Stay Away' From This EV Maker, It 'Should Not Be Public' - Alnylam Pharmaceuticals  ( NASDAQ:ALNY ) , Accenture  ( NYSE:ACN ) ",20230908T132402,https://www.benzinga.com/trading-ideas/long-ideas/23/09/34358199/cramer-says-please-stay-away-from-this-ev-maker-it-should-not-be-public,ALNY,0.44622,Bullish,0.369907
